glp 1 va study Quitting GLP-1s Could Hurt Heart Health, Return Lost Weight: Glucagon-like peptide-1 receptor agonists and

Methods and analysis Study design and setting This two-arm randomized controlled trial is designed to evaluate the efficacy and safety of GLP-1RAs in cigarette smoking cessation compared with control treatment

Kuner, T

Exogenous glutamine impairs neutrophils migration into infections sites elicited by lipopolysaccharide by a multistep mechanism

After months of steady progress, some researchers find that tirzepatide stops producing weight loss even at maximum doses

Relative to comparators, the risk for any of the commonly used cardiovascular end points was estimated to be below 1.0, and for both MACE-4 and MACE-3 (myocardial infarction, stroke, and all-cause death), the upper bounds of the confidence interval calculated around the hazard ratio were decidedly 8.5 %